Addition of metformin to non-small-cell lung cancer patients with or without diabetes

Thorac Cancer. 2023 Jan;14(2):218-219. doi: 10.1111/1759-7714.14756. Epub 2022 Nov 30.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / complications
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Diabetes Mellitus, Type 2*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Lung Neoplasms* / complications
  • Lung Neoplasms* / drug therapy
  • Metformin* / therapeutic use

Substances

  • Metformin
  • Hypoglycemic Agents